TEM's Genomics unit is expected to report strong growth for the fourth quarter, banking on continued unit growth pick-up.

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday. The stock appears to be moving on continued momentum from ...

Tempus AI stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge ...

Tempus AI’s strategic moves and groundbreaking technological applications mark it as a key player in the future of precision ...

In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against other buzzing AI stocks on ...

Shares of Tempus AI (NASDAQ:TEM) are soaring 36% higher in midday trading after it was revealed former House Speaker Nancy ...